Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA

D. G. Ahn, S. B. Shim, J. E. Moon, J. H. Kim, S. J. Kim, J. W. Oh

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The RNA-dependent RNA polymerase (RdRp) of hepatitis C virus (HCV) is the essential catalytic enzyme for viral genome replication. It initiates minus-strand RNA synthesis from a highly conserved 98-nt sequence, called the X-RNA, at the 3'-end of the plus-strand viral genome. In this study, we evaluated the antiviral effects of peptide nucleic acids (PNAs) targeting the X-RNA. Our in vitro RdRp assay results showed that PNAs targeting the three major stem-loop (SL) domains of X-RNA can inhibit RNA synthesis initiation. Delivery of X-RNA-targeted PNAs by fusing the PNAs to cell-penetrating peptides (CPPs) into HCV-replicating cells effectively suppressed HCV replication. Electrophoretic mobility shift assays revealed that the PNA targeting the SL3 region at the 5'-end of X-RNA dissociated the viral RdRp from the X-RNA. Furthermore, delivery of the SL3-targeted PNA into HCV-infected cells resulted in the suppression of HCV RNA replication without activation of interferon β expression. Collectively, our results indicate that the HCV X-RNA can be effectively targeted by CPP-fused PNAs to block RNA-protein and/or RNA-RNA interactions essential for viral RNA replication and identify X-RNA SL3 as an RdRp binding site crucial for HCV replication. In addition, the ability to inhibit RNA synthesis initiation by targeting HCV X-RNA using antisense PNAs suggests their promising therapeutic potential against HCV infection.

Original languageEnglish
Pages (from-to)e298-e306
JournalJournal of Viral Hepatitis
Volume18
Issue number7
DOIs
Publication statusPublished - 2011 Jul 1

Fingerprint

Peptide Nucleic Acids
Virus Replication
Hepacivirus
Cell Culture Techniques
RNA
RNA Replicase
Cell-Penetrating Peptides
Viral Genome
Viral RNA
RNA Polymerase III
Antisense RNA
Electrophoretic Mobility Shift Assay
Virus Diseases

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Infectious Diseases
  • Virology

Cite this

Ahn, D. G. ; Shim, S. B. ; Moon, J. E. ; Kim, J. H. ; Kim, S. J. ; Oh, J. W. / Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA. In: Journal of Viral Hepatitis. 2011 ; Vol. 18, No. 7. pp. e298-e306.
@article{431625e76b1e4124a1b8ba1fc224c69b,
title = "Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA",
abstract = "The RNA-dependent RNA polymerase (RdRp) of hepatitis C virus (HCV) is the essential catalytic enzyme for viral genome replication. It initiates minus-strand RNA synthesis from a highly conserved 98-nt sequence, called the X-RNA, at the 3'-end of the plus-strand viral genome. In this study, we evaluated the antiviral effects of peptide nucleic acids (PNAs) targeting the X-RNA. Our in vitro RdRp assay results showed that PNAs targeting the three major stem-loop (SL) domains of X-RNA can inhibit RNA synthesis initiation. Delivery of X-RNA-targeted PNAs by fusing the PNAs to cell-penetrating peptides (CPPs) into HCV-replicating cells effectively suppressed HCV replication. Electrophoretic mobility shift assays revealed that the PNA targeting the SL3 region at the 5'-end of X-RNA dissociated the viral RdRp from the X-RNA. Furthermore, delivery of the SL3-targeted PNA into HCV-infected cells resulted in the suppression of HCV RNA replication without activation of interferon β expression. Collectively, our results indicate that the HCV X-RNA can be effectively targeted by CPP-fused PNAs to block RNA-protein and/or RNA-RNA interactions essential for viral RNA replication and identify X-RNA SL3 as an RdRp binding site crucial for HCV replication. In addition, the ability to inhibit RNA synthesis initiation by targeting HCV X-RNA using antisense PNAs suggests their promising therapeutic potential against HCV infection.",
author = "Ahn, {D. G.} and Shim, {S. B.} and Moon, {J. E.} and Kim, {J. H.} and Kim, {S. J.} and Oh, {J. W.}",
year = "2011",
month = "7",
day = "1",
doi = "10.1111/j.1365-2893.2010.01416.x",
language = "English",
volume = "18",
pages = "e298--e306",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell",
number = "7",

}

Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA. / Ahn, D. G.; Shim, S. B.; Moon, J. E.; Kim, J. H.; Kim, S. J.; Oh, J. W.

In: Journal of Viral Hepatitis, Vol. 18, No. 7, 01.07.2011, p. e298-e306.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA

AU - Ahn, D. G.

AU - Shim, S. B.

AU - Moon, J. E.

AU - Kim, J. H.

AU - Kim, S. J.

AU - Oh, J. W.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - The RNA-dependent RNA polymerase (RdRp) of hepatitis C virus (HCV) is the essential catalytic enzyme for viral genome replication. It initiates minus-strand RNA synthesis from a highly conserved 98-nt sequence, called the X-RNA, at the 3'-end of the plus-strand viral genome. In this study, we evaluated the antiviral effects of peptide nucleic acids (PNAs) targeting the X-RNA. Our in vitro RdRp assay results showed that PNAs targeting the three major stem-loop (SL) domains of X-RNA can inhibit RNA synthesis initiation. Delivery of X-RNA-targeted PNAs by fusing the PNAs to cell-penetrating peptides (CPPs) into HCV-replicating cells effectively suppressed HCV replication. Electrophoretic mobility shift assays revealed that the PNA targeting the SL3 region at the 5'-end of X-RNA dissociated the viral RdRp from the X-RNA. Furthermore, delivery of the SL3-targeted PNA into HCV-infected cells resulted in the suppression of HCV RNA replication without activation of interferon β expression. Collectively, our results indicate that the HCV X-RNA can be effectively targeted by CPP-fused PNAs to block RNA-protein and/or RNA-RNA interactions essential for viral RNA replication and identify X-RNA SL3 as an RdRp binding site crucial for HCV replication. In addition, the ability to inhibit RNA synthesis initiation by targeting HCV X-RNA using antisense PNAs suggests their promising therapeutic potential against HCV infection.

AB - The RNA-dependent RNA polymerase (RdRp) of hepatitis C virus (HCV) is the essential catalytic enzyme for viral genome replication. It initiates minus-strand RNA synthesis from a highly conserved 98-nt sequence, called the X-RNA, at the 3'-end of the plus-strand viral genome. In this study, we evaluated the antiviral effects of peptide nucleic acids (PNAs) targeting the X-RNA. Our in vitro RdRp assay results showed that PNAs targeting the three major stem-loop (SL) domains of X-RNA can inhibit RNA synthesis initiation. Delivery of X-RNA-targeted PNAs by fusing the PNAs to cell-penetrating peptides (CPPs) into HCV-replicating cells effectively suppressed HCV replication. Electrophoretic mobility shift assays revealed that the PNA targeting the SL3 region at the 5'-end of X-RNA dissociated the viral RdRp from the X-RNA. Furthermore, delivery of the SL3-targeted PNA into HCV-infected cells resulted in the suppression of HCV RNA replication without activation of interferon β expression. Collectively, our results indicate that the HCV X-RNA can be effectively targeted by CPP-fused PNAs to block RNA-protein and/or RNA-RNA interactions essential for viral RNA replication and identify X-RNA SL3 as an RdRp binding site crucial for HCV replication. In addition, the ability to inhibit RNA synthesis initiation by targeting HCV X-RNA using antisense PNAs suggests their promising therapeutic potential against HCV infection.

UR - http://www.scopus.com/inward/record.url?scp=79959581076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959581076&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2893.2010.01416.x

DO - 10.1111/j.1365-2893.2010.01416.x

M3 - Article

C2 - 21692941

AN - SCOPUS:79959581076

VL - 18

SP - e298-e306

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 7

ER -